1. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
   Gislaine Z. Réus et al, 2023, Neuroscience & Biobehavioral Reviews CrossRef
2. Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro
   Malin Wennström et al, 2014, PLoS ONE CrossRef
3. Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
   Shigeyuki Chaki et al, 2015, Pharmaceuticals CrossRef
4. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release
   Emilio Russo et al, 2014, Brain, Behavior, and Immunity CrossRef
5. Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model
   Xiao-Hui Tang et al, 2020, Journal of Neuroinflammation CrossRef
6. Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
   Emma Kopra et al, 2021, Journal of Psychopharmacology CrossRef
7. Chronic lipopolysaccharide impairs motivation when delivered to the ventricles, but not when delivered peripherally in male rats
   Kristen M. Pechacek et al, 2022, Physiology & Behavior CrossRef
8. Ketamine: A Neglected Therapy for Alzheimer Disease
   Neil R. Smalheiser, 2019, Frontiers in Aging Neuroscience CrossRef
9. Dysregulation of inflammation, neurobiology, and cognitive function in PTSD: an integrative review
   Maria M. Quinones et al, 2020, Cognitive, Affective, & Behavioral Neuroscience CrossRef
10. Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors
    Jia-Mei Li et al, 2019, Neuropharmacology CrossRef
11. Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro
    Guo-Hua Wu et al, 2023, Metabolic Brain Disease CrossRef
12. Sevoflurane Exerts an Anti-depressive Action by Blocking the HMGB1/TLR4 Pathway in Unpredictable Chronic Mild Stress Rats
    Zhenggang Guo et al, 2019, Journal of Molecular Neuroscience CrossRef
13. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression — A central role for the serotonin transporter?
    Jana Haase et al, 2015, Pharmacology & Therapeutics CrossRef
14. Treadmill exercise sex-dependently alters susceptibility to depression-like behaviour, cytokines and BDNF in the hippocampus and prefrontal cortex of rats with sporadic Alzheimer-like disease
    Saeed Naghibi et al, 2021, Physiology & Behavior CrossRef
15. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
    F. Caraci et al, 2018, Pharmacological Reviews CrossRef
16. The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
    Alice Hartmann et al, 2023, Current Neuropharmacology CrossRef
17. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
    Rita Citraro et al, 2016, Pharmacological Research CrossRef
18. Immunoregulation and antidepressant effect of ketamine
    Nan Zhang et al, 2021, Translational Neuroscience CrossRef
19. Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions
    Zümrüt Duygu Sen et al, 2021, Brain, Behavior, and Immunity CrossRef
20. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
    Kristian Gaarn du Jardin et al, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
21. The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
    Nan Wang et al, 2015, Upsala Journal of Medical Sciences CrossRef
22. Antinociceptive and Anti‐Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition
    Eduardo Mulato do Vale et al, 2016, Basic & Clinical Pharmacology & Toxicology CrossRef